United Therapeutics reported $20.8M in Interest Income for its fourth fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Interest Income Change
Baxter International BAX:US USD 8M 3M
BioCryst Pharmaceuticals BCRX:US USD 2.7M 944K
Biogen BIIB:US USD 49.9M 26M
BioMarin Pharmaceutical BMRN:US USD 8.71M 3.71M
Esperion Therapeutics ESPR:US USD 900K 100K
Intra Cellular Therapies ITCI:US USD 3.39M 1.26M
Moderna Inc MRNA:US USD 87M 29M
Pfizer PFE:US USD 137M 67M
Sangamo BioSciences SGMO:US USD 3.68M 1.91M
Sarepta Therapeutics SRPT:US USD 9.13M 4.35M
United Therapeutics UTHR:US USD 20.8M 7.5M
Vertex Pharmaceuticals VRTX:US USD 86M 39.8M